The aim of radical prostatectomy (RP) is the complete removal of the prostate gland with negative surgical margins. The presence of cancer at the surgical margin is associated with higher probability of disease progression. Current methods of intraoperative margin assessment are inaccurate or time-consuming. The study goal was to evaluate the ability of a novel device (Dune Medical Devices) to differentiate between cancer and BPH. METHODS: A total of 49 patients undergoing RP in four medical centers between November 2007 and May 2008 were enrolled in this study. The device was applied to numerous intra-and extra-capsular sites of freshly excised RP specimens. Measurement sites were accurately marked and analyzed histologically. The ability of the device to differentiate between malignant and nonmalignant sites was assessed. RESULTS: A total of 15 156 measurements from 45 patients were analyzed. Differentiation of the intra-capsular malignant sites from extra-capsular nonmalignant sites (bladder neck and apex regions) depends on the cancer feature size. Differentiation was achieved with sensitivity and specificity of 93.6 (95% confidence interval (CI): 88-98) and 94.1 (95% CI: 93-95), respectively, at feature sizes at or 40.8 mm in diameter. The device was able to discriminate between all intra-capsular malignant (with feature sizes down to a few cells) and nonmalignant measurement sites, with sensitivity and specificity of 80.8 (95% CI: 73-87) and 68.4 (95% CI: 67-69), respectively. CONCLUSIONS: First results from a radio-frequency near-field spectroscopy sensor look promising for differentiation between cancer and benign prostate tissue. The sensor's dimensions (radius of B1 mm) and design enable use in open, laparoscopic and robotic RP to evaluate the surgical margins intraoperatively.
INTRODUCTION
Radical prostatectomy (RP) is a standard method of treatment for localized prostate cancer. The goals of the procedure include cancer control and postoperative preservation of continence and potency. [1] [2] [3] Oncological control following RP depends on several aspects such as tumor stage, histological tumor grade and margins of resection status. The presence of cancer cells at the margin of the surgical specimen suggests incomplete removal of the tumor and can be associated with significantly increased probability of disease progression. Positive surgical margin (PSM) is not uncommon following RP, with an incidence of 11-38% according to contemporary series. [4] [5] [6] [7] Positive margins occur more often in patients with nonorgan-confined disease (22-53%); however, its range among patients with organ-confined disease is not insignificant (3-18%) . Achieving complete tumor removal with negative surgical margins can be aided by prediction of extra-prostatic extension according to preoperative digital rectal examination, imaging techniques and other prediction tools. [8] [9] Although resection of the periprostatic tissue, especially the neurovascular bundle at the posterolateral aspect of the prostate, can lead to a lower rate of PSM, it may reduce the rate of postoperative erectile function. [10] [11] [12] [13] Intraoperative information regarding the presence or absence of tumor at the surgical margin can be assessed by specimen palpation, which is highly inaccurate, or by frozen section (FS), which can be precise 14 but is labor intensive and time-consuming. [15] [16] [17] [18] [19] To improve intraoperative margin evaluation, a new device (Dune Medical Devices, Caesarea, Israel) that can detect tumor cells at or close to the margin of resection has been developed. The probe is sensitive enough to detect small changes in tissue frequency-dependent dielectric properties (permittivity and conductivity) caused by changes to the tissue physiology. These properties determine the tissue effect on incident electromagnetic waves. It is well established that these properties change as tissue turns from normal to malignant in various human organs. charges) and the permittivity (the measure of the ability to store electric charges) of the tissue in the radio frequency (RF) range. The aim of the current study was to prospectively investigate the ability of the device in detecting prostate cancer vs benign prostatic tissue present in and on RP specimens. Such devices were previously tested on breast tissue 23 and showed potential for detecting positive margins on lumpectomy specimens 24 and reducing repeat breast-conserving surgeries. 25 The differences in dielectric properties between normal and malignant prostate tissues were previously described and measured, 26 and when combined with optical spectroscopy, were shown to give high differentiation between the tissue types. 27 
MATERIALS AND METHODS

General design
Tissue measurements were performed on freshly excised RP specimens. Measurements were compared with histological analysis. All medical staff members were blinded to device output. Measurements were taken from the surface at apex and bladder neck resection areas, as well as from intraprostatic areas during whole-mount sectioning of the specimen. In the intraprostatic areas, exact registration was maintained between measured sites and the histological analysis. Specimen handling before and after measurements was performed according to routine procedures.
Measurements (16 221) were taken from 45 patients who underwent RP. All patients signed an informed consent permitting the clinical investigation before any study-related procedures. Patients were enrolled in four medical centers from November 2007 through May 2008. Inclusion criteria specified patients over 18 years of age, undergoing RP.
Device description
The device (Dune Medical Devices) used in this study is a near-field RF spectroscopy-based real-time detection device. It consists of a hand-held probe, connected by cables to a console. The console sends RF waves over a large frequency range, transmitted to the tissue through the sensor. The RF signals are reflected from the tissue through the sensor, and are received by the console. The effective measurement area of the sensor is a 0.8-mm-diameter circle, and its penetration depth is B0.1-0.2 mm. The mechanical footprint of the probe is 2 mm in diameter. Each measurement takes B1-3 s to complete.
The reflection signals are translated into tissue properties (permittivity and conductivity) by a transformation based on the probe characteristics (geometry and materials) and the RF frequencies. Typical dielectric properties of cancerous tissue and benign prostatic tissue in the RF range are presented in Figure 1 .
Tissue measurements and processing
Measurements were taken from the apical and bladder neck surface, following excision and before routine processing of the specimen. In all, 40-80 measurements were taken at each region, partially covering it. Each of these measurement zones had 8 circles marked with a tissue marker and 10 measurements were taken inside each circle to cover its area ( Figure 2) . The circles were then inked with four different colors ( Figure 2 ). Right and left orientation of the circles was generated by routine tissue orientation. 28 The specimen was then fully inked and sliced into five to seven transverse sections, B4-6 mm thick, in such a way that the bladder neck and apex remained intact. These last two were sent for routine processing. 29 In addition, one to three transverse-cut sections were sampled by the probe in the following manner: specially designed stencils were placed on the measured side of the slice. These stencils contained a matrix of holes, 2 mm in diameter, that accommodated the probe's distal end, enabling it to contact the tissue surface. The probe was manually handled to measure all measurement sites of the slice through the stencil ( Figure 3 ). Each individual measurement took 1-3 s to complete. Designated software helped the user to measure and save the data accurately according to the measurement's-specific position within the stencil matrix. The relative orientation of the stencil and the prostate tissue was recorded. Once a slice was fully measured it was fixed. The slices were removed from the solution and further processed following fixation (24-48 h). Finally, histological slides were prepared for each slice measured, incorporating all the measurement sites within the slice. The position of the individual measurement sites relative to their location in the stencil was kept to accurately compare the device output and the site histology. The inset in Figure 3 shows four such measurement sites on a histology slide, with their respective stencil coordinate. It is estimated that the potential registration error between the actual measured tissue site and the analyzed tissue circle on the slide was o0.1 mm.
In summary, the majority of measurements were taken using the specially designed stencils, within the specimen itself on transverse-cut cross sections, enabling accurate registration between measurement and 0.8 histopathology analysis. Measurements from the specimen margins were taken only from the apical and bladder neck regions.
Data analysis
Tissue. Each 2-mm-measurement site was histologically analyzed in the stenciled slices. Each measurement site was denoted as malignant (if tumor was found) or nonmalignant. The malignant sites were divided into five groups named according to the percentage of malignant area covering the 2 mm-diameter tissue sites: 0, 25, 50, 75 and 100%. The coverage areas were rounded to the nearest value, where the '0%' group is the group that contains all samples with the lowest number of cancer features detected by histology. The nonmalignant tissue types were classified according to the predominant histology of the 2 mm-diameter measurement site (for example, stroma, muscle and high-grade prostatic intraepithelial neoplasia).
Measurements. Measurements performed by the device were logged together with their corresponding registration data. The dielectric properties (dielectric constant and conductivity) of each measured tissue site were extracted at all measured frequencies.
Classification algorithm. The dielectric properties of each measured point were combined into a single score variable. The score variable was calculated as a linear combination (using linear discriminant analysis) 30 of the dielectric properties that exhibited differentiation between malignant and nonmalignant measurements in a selected learning group subset of the full data set. Device output (positive/negative) for each measurement was determined by placing a threshold (cutoff point) on the score variable. Measurements with a score value lower than the threshold were defined as being positive, and those above the threshold were defined as being negative. The chosen subset for the derivation of the score variable was the data set including all measurements of histologically negative sites from the bladder neck and apex regions from all patients (3571 measurements), and the cancerous sites of the '100%' group (125 measurements). These subset measurement data are presented in Figure 4 , in which the nonmalignant measurement sites are visible in blue and the cancerous sites in red. The horizontal and vertical axes are the first and second canonical variables, 30 respectively. The score variable was chosen simply to be the first canonical variable, along which the cutoff points were scanned. The cutoff threshold is presented in Figure 4 by a vertical dashed line. At a specific cutoff value the algorithm declares all measurements with a smaller value (to the left of the line) as positive, and all measurements with higher values as negative. All performance analyses were carried out using each cutoff value. Device indication (positive/ negative) of qualified measurements was compared with tissue histology on a per measurement site basis. The threshold levels (cutoff points) of the score variable were scanned to generate receiver operating characteristic (ROC) curves. Analyses were performed on several subsets of the data. Sensitivity and specificity at the optimal cutoff points (points on the ROC curve closest to the upper left corner of the axes) were extracted for each subset. Most importantly, the choice of a subset for the score variable derivation did not affect results-changes to the area under the ROC curves and to the sensitivity, specificity and optimal cutoff points were well below the s.d. Specifically, score variables were derived for each analyzed subset (by using the whole subset or randomly chosen halves of it) and the results did not change relative to the main score variable analysis described above.
RESULTS
Out of 49 enrolled patients, 45 were analyzed (their baseline characteristics appear in Table 1 ). Three were screen failures (2 had benign disease, one had sarcoma) and one had faulty wholemount slide processing. In the 45 patients included in the analysis 16 221 measurements were performed: 4076 in the bladder neck and apex regions and 12 145 in the slices using stencils. In total, 914 measurements were disqualified, using predefined thresholds, due to irregular RF reflection signals attributed to improper attachment of the probe to the tissue. In addition, 151 (4%) measurements from the apex and bladder neck regions were excluded due to inaccurate registration between an individual measurement location and its corresponding histology. Altogether, 15 156 measurements were analyzed. The distribution of tissue histology of all qualified tissue measurements is shown in Figure 5 . The histological findings appearing most frequently, benign prostate tissue, muscle, prostatic stroma, high-grade prostatic intraepithelial neoplasia and cancer, are presented separately. Types that appeared rarely in the histological analysis (fat, urethra, blood vessels, hyperplasia, inflammation, cysts, atrophy and metaplasia) were grouped under 'Other'. Beside muscle tissue, which was found only in the bladder neck and apex regions, the various tissue types appeared in all areas measured. Prostate cancer was observed in 1139 (7.5%) samples, noncancerous prostatic tissue in 6662 (44%) and non-prostatic tissue in 7355 (48.5%).
The ROC curve presenting the differentiation ability between all nonmalignant sites with accurate registration (10 446 ) and the homogeneous malignant sites, the '100%' group (125), is shown in Figure 6 . The area under the curve and sensitivity and specificity at the optimal threshold (the point closest to the upper left corner of the graph) are 0.79 (95% confidence interval (CI): 0.78-0.8), 80.8 (95% CI: 73-87) and 68.4 (95% CI: 67-69), respectively ( Table 2) .
The ROC curves comparing differentiation ability of the various malignant groups, with varying feature sizes, from the nonmalignant measurements taken from the bladder neck and apex regions (3571) are shown in Figure 7 . The two additional malignant groups presented here, '0% þ 25%' and '50% þ 75%', numbered 656 and 358 samples, respectively. The separation ability increases as the homogeneity and feature size of the malignant sites increases, from an area under the curve of 0.908 (95% CI: 0.9-0.92) to 0.976 (95% CI: 0.97-0.98; Table 2 ). Note that in the '0% þ 25%' group cancer feature sizes included anything detectable by histopathology, down to a cluster of a few cells. Separation ability did not depend on patient or tumor characteristics such as age, preoperative PSA or Gleason score. Figure 8 shows the ROC curve for separation between all the nonmalignant measurements taken from the bladder neck and apex regions and the benign prostate tissue measurements taken inside the prostate using the stencils (6374 sites, Figure 5 ). The area under the curve is 0.895 (95% CI: 0.89-0.90).
DISCUSSION
PSM can be associated with incomplete removal of the prostate gland (intraprostatic margin) or advanced disease in which the tumor already penetrated the capsule (extraprostatic margin). Patients with a PSM have a higher probability of disease progression and need additional salvage radiotherapy following surgery. The current methods to assess the status of the surgical margin during RP are limited. In this study, we assessed the ability of a RF near-field spectroscopy device to differentiate between malignant and benign prostatic tissue at the apex and bladder neck during retropubic RP.
The performance assessed in 0.8 mm and up cancer feature sizes was around 95% for both sensitivity and specificity, with an area under the curve of 0.976, representing the high capability of the technology. The large number of patients and samples provides very narrow CIs for the results. The probe also showed an ability to detect cancer features that were of fractional coverage of the sensing area, down to well o1 mm in dimension, although as expected, there was some decrease in performance relative to the '100%' group. In measurement sites from fractional coverage groups, the sensor footprint was partially facing cancerous tissue and effectively came into contact with smaller cancer feature sizes. In particular, in the '0-25%' group it is also possible that some of the misdetections were due to the sensor not coming into contact with malignant tissue at all, as the sensor diameter is 0.8 mm and the sample analyzed is 2 mm in diameter. This challenge might be avoided with optimization of the size of the sensing area (downor up-scaled) to match the minimal feature size that is required for identification. We have also shown high differentiation capabilities between intra-capsular malignant and nonmalignant prostatic tissue, with sensitivity and specificity of 80.8% and 68.4%, respectively.
In this study, measurements were taken on the specimen B30 min after excision, after ischemia has taken place, as well as other changes, for example, temperature and dehydration. To test the ability of a future device to perform intraoperative assessment of margins, whether in vivo or immediately after excision, further studies will be needed. The methods to reduce PSM include optimizing the surgical technique, which is beyond the aim of this study, and intraoperative monitoring of surgical margin status. Accuracy of intraoperative FS for evaluation of surgical margin status varies. Tsuboi et al. 16 used FS during open RP in 259 patients out of 760 procedures. The sensitivity, specificity, positive and negative predictive values were 42%, 100%, 100% and 86%, respectively. Dillenburg et al. 17 showed that FS in a population of laparoscopic RP had specificity and sensitivity of 96 and 70%. Similar results were shown by Lepor et al. 19 (sensitivity of 58%) and Goharderakhshan et al. 18 (sensitivity of 69%), but if the sensitivity would have been calculated in all the areas in addition to those submitted for FS analysis the sensitivity would decrease to 40.7%. Therefore, in all four reports, FS had reduced sensitivity (42-70%). Additional disadvantages of intraoperative FS include its length (estimated to be between 20 and 30 min), limited number of samples and limited available personnel for its analysis. High accuracy (sensitivity and specificity of 93.5% and 98.8%, respectively) was reported by Schlomm et al., 14 on a retrospective study on 11 069 patients undergoing nerve-sparing RP, by using a labor-intensive, high sampling of the whole laterorectal circumference of the prostate. A device such as the one presented here can be an alternative for intraoperative FS. The information on extensive areas of the excised specimen, as well as the surgical cavity, is delivered in several minutes, in a setting in which additional resection of tissue is possible immediately following a positive indication by the device at the appropriate location.
An optimal balance between oncological therapeutic goals and quality of life preservation, for example, by achieving clear margins and minimizing damage to the neurovascular bundles, might be met by real-time intraoperative tissue characterization during prostatectomy procedures.
CONCLUSIONS
The results of this study demonstrate a strong potential for future use of the Dune device for differentiating benign and malignant prostate tissue in the relevant resection areas of RP specimens. The study was performed on freshly excised specimens. To determine the device's ability to detect residual cancer in vivo, thus enabling surgeons to avoid PSM intraoperatively, additional studies of device use during RP procedures are needed. 
